CL
Clague Laura Chief Financial Officer
Other F
US US · SEC (Form 4)
Discover the full record of transactions filed by Clague Laura, Chief Financial Officer. Officer active across 4 companies, notably Travere Therapeutics, Inc.. Cumulatively, 17 filings have been recorded. Total volume traded: €171k. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations 17 total
030,914 shares 0
Common Stock
SEC:0001162194-22-000075:0 · 15 Jun 2022
€16,848 825 shares @ €20.4216 0.0004% mcap 9.9% of flow
Common Stock
SEC:0001209191-22-028707:0 · 10 May 2022
€63,003 50,000 shares @ €1.2601 0.077% mcap 62.3% of flow
Common Stock
SEC:0001437749-22-009944:0 · 27 Apr 2022
30,000 shares
Common Stock
SEC:0001437749-22-006570:0 · 15 Mar 2022
€38,132 20,000 shares @ €1.9066 0.047% mcap 37.7% of flow
Common Stock
SEC:0001437749-22-004289:0 · 23 Feb 2022
09,840 shares 0
Common Stock
SEC:0001209191-22-006362:0 · 31 Jan 2022
09,840 shares 0
Common Stock
SEC:0001209191-22-006362 · 31 Jan 2022
€45,438 2,063 shares @ €22.0254 0.0011% mcap 59.0% of flow
Common Stock
SEC:0001209191-22-005080 · 24 Jan 2022
€45,438 2,063 shares @ €22.0254 0.0011% mcap 26.6% of flow
Common Stock
SEC:0001209191-22-005080:0 · 24 Jan 2022
07,500 shares 0
Common Stock
SEC:0001209191-22-003046 · 10 Jan 2022
07,500 shares 0
Common Stock
SEC:0001209191-22-003046:0 · 10 Jan 2022
04,500 shares 0
Common Stock
SEC:0001209191-21-052077 · 13 Aug 2021
04,500 shares 0
Common Stock
SEC:0001209191-21-052077:0 · 13 Aug 2021
010,342 shares 0
Common Stock
SEC:0001162194-21-000059 · 25 May 2021
010,342 shares 0
Common Stock
SEC:0001162194-21-000059:0 · 25 May 2021
€31,520 2,000 shares @ €15.7602 0.0008% mcap 41.0% of flow
Common Stock
SEC:0001209191-21-032314 · 11 May 2021
€31,520 2,000 shares @ €15.7602 0.0008% mcap 18.5% of flow
Common Stock
SEC:0001209191-21-032314:0 · 11 May 2021
About Clague Laura Laura Clague is associated with Travere Therapeutics, Inc.